Skip to main content
. Author manuscript; available in PMC: 2019 Jan 6.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2017 Oct 2;58:231–252. doi: 10.1146/annurev-pharmtox-010617-052645

Table 2.

Representative small-molecule modulators with other or unknown targetsa

Small molecules Target activity Circadian phenotype Physiological effects References
Opsinamides Melanopsin
 inhibitors
Suppress light input to
 the SCN
Generally suppress nonvisual
 photoresponse
81
SB432542 ALK5 inhibitor Attenuate phase delay Inhibit TGF-β signaling 82
AICAR, metformin AMPK activator Lengthen period
Reduce amplitude
AICAR: exercise mimetic
Metformin: antidiabetic
43, 168
CKI-7, IC261, D4476,
 PF-670462, longdaysin,
 LH846, Compound 1-3, and others
CK1 inhibitor Lengthen period CK1 is broadly involved in
 various pathophysiologies,
 including familial sleep
 and mood disorders
75, 78
PF-4800567 Selective CK1 ε
 inhibitor
Blocks PER2
 degradation but shows
 minimal effects on
 circadian period
Increases sensitivity to
 psychostimulants and opioids
73
DRB, DMAT CK2 inhibitor Lengthen period Antineoplasia 78, 169
Lithium GSK3 β inhibitor Lengthen period
Enhance amplitude
Mood disorders 125, 170
Chir99021,
 1-azakenpaullone,
 indirubin
GSK3 β inhibitor Shorten period Improve glucose metabolism,
 anti-inflammatory and
 antiangiogenesis
62
L-Methyl selenocysteine Enhance Bmal1
 transcription
Induction of BMAL1
 protein level and
 activity
Improved survival of
 cyclophosphamide-sensitive
 Clock mutant mice
69
Resveratrol Sirt1 activator Modulate physiological
 rhythms and clock gene
 expression
Broad physiological and
 antiaging efficacies
140
SRT2183, SRT1720,
 SRTCD1023,
 SRTCL1015
Sirt1 activator Reduce circadian
 expression
Lengthen period
Reduce amplitude
Improve circadian clock gene
 expression
Reduce inflammation in
 chronic obstructive pulmonary
 disease
143, 171
OPC-21268, SSR 149415 Antagonists for
 arginine vasopressin
 receptors
 V1a and V1b, respectively
Accelerate entrainment
 to jet lag
Accelerate reentrainment after
 jet lag and shift work
109
Compound 5, a
 benzodiazepine
 derivative
GABA receptor
 agonist
Acts on an unknown
 target
Lengthens period in
 both SCN and
 peripheral clocks
NA 66
Compound 10/CEM3 Unknown Enhance amplitude and
 shorten period in both
 SCN and peripheral
 clocks
NA 61,66

Abbreviations: AMPK, AMP-activated protein kinase; CEM, clock-enhancing small molecule; CK1, casein kinase 1; CK2, casein kinase 2; GABA, γ-aminobutyric acid; GSK3 β, glycogen synthase kinase 3 β; NA, not applicable; PER, period; SCN, suprachiasmatic nucleus; TGF-β, transforming growth factor-β.

a

For additional related compounds and references, please refer to a recent review (78).